ÑÇÐÇÓÎÏ·¹ÙÍø-www.yaxin868.com

ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾Ï³´²¹Ù·½ÍøÕ¾½ñÌìÊÇ£º2025-06-06Çл»³ÇÊÐ[È«¹ú]-ÍøÕ¾µØÍ¼
ÍÆ¼ö²úÆ· :
ÍÆ¼öÐÂÎÅ
¼¼ÊõÎÄÕµ±Ç°Î»ÖÃ:¼¼ÊõÎÄÕÂ>

Ò»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨

ʱ¼ä:2023-06-15    ×÷Õß: ¹ÜÀíÔ±

Ò»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨
¡¾×¨ÀûÕªÒª¡¿±¾·¢Ã÷Êôҽѧ¼ìÑéÁìÓò£¬±¾·¢Ã÷µÄÄ¿µÄÔÚÓÚÌṩһÖÖ¿ÉÒÔ׼ȷ²â¶¨Ñª½¬»òѪÇåÑùÆ·ÖÐÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬±¾·¢Ã÷µÄ·½·¨¿ÉÓÃÓÚ׼ȷ¡¢¼ò±ã¡¢¿ìËÙµØÆÀ¼Û°×Ѫ²¡»¼ÕßÖÎÁÆÒ©ÎïÃŶ¬õ£°·Ã¸µÄÌåÄÚҩЧ¡£±¾·¢Ã÷²ÉÓÃÒºÖÊÁªÓÃÖÊÆ×ÒÇÀ´²â¶¨Ñª½¬»òѪÇåÑùÆ·ÖÐÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶È£¬¸Ã·½·¨°üÀ¨£ºA¡¢¿Õ°×»ùÖÊ´¦Àí£»B¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄǰ´¦Àí£»C¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄ·ÖÀëÓë·ÖÎö¡£
¡¾×¨Àû˵Ã÷¡¿Ò»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨
¡¾¼¼ÊõÁìÓò¡¿
[0001]±¾·¢Ã÷Êôҽѧ¼ìÑéÁìÓò£¬¾ßÌåÉæ¼°Ò»ÖÖÒºÖÊÁªÓòⶨÌåÄÚÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨¡£
¡¾±³¾°¼¼Êõ¡¿
[0002]ÃŶ¬õ£°·Ã¸(L-asp)ÖÎÁƼ±ÐÔÁܰÍϸ°û°×Ѫ²¡(ALL)ÒѾ­ÓÐ30¶àÄêµÄÀúÊ·£¬¸÷¹úÑо¿±¨µÀALLÓÕµ¼·½°¸ÖÐÌí¼ÓL-aspÄܹ»Ìá¸ßÍêÈ«»º½âÂÊ(CR)ºÍÖÎÓúÂÊ£¬ÌرðÊǼ±ÐÔBÁܰÍϸ°û°×Ѫ²¡ÖÎÁÆÖÐ5ÄêÎÞʼþÉú´æÂʿɴﵽ76-86%(²Î¿¼ÎÄÏ×:l.Pui£¬C.H.£¬Carroll, W.L.£¬Meshinchij S.£¬Mrcecij R.J.Biology, risk stratification, andtherapy of pediatric acute leukemias: An update.Journal of ClinicalOncology, 2011; 29 (5):551-565.2.ÖйúÁÙ´²Ö×Áöѧ»á(CSCO)£¬ÖлªÒ½Ñ§»áѪҺѧ·Ö»á(CHS)£¬Öлª¶ù¿ÆÑªÒºÑ§·Ö»á(CCHS).ÅàÃŶ¬Ã¸ÖÎÁƼ±ÐÔÁܰÍϸ°û°×Ѫ²¡ºÍ¶ñÐÔÁܰÍÁöµÄר¼Ò¹²Ê¶[J].ÁÙ´²Ö×ÁöѧÔÓÖ¾£¬2013; 18(3):256-263.3.Rowe JM, Buck G£¬Burnett AK£¬et al.1nduction therapy for adults with acute lymphoblastic leukemia:resultsof more thanl500patients from the international ALL trial:MRC UKALLXIVECOGE2993 [J].Blood, 2005;106(12):3760-3767.)¡£
[0003]L-asp¶ÀÌØ×÷ÓûúÖÆÔÚÓÚË®½âѪҺÖÐÓÎÀëµÄÃŶ¬õ£°·ÎªL-ÃŶ¬°±ËáºÍ°±£¬Õý³£Ï¸°ûº¬ÓÐÃŶ¬õ£°·ºÏ³ÉøÄܺϳÉ×ãÁ¿ÃŶ¬õ£°·¹©×ÔÉíÉú³¤£¬¼±ÐÔÁܰÍϸ°ûµÈÖ×Áöϸ°ûÒòȱ·¦ÃŶ¬õ£°·ºÏ³Éøµ¼Öµ°°×ÖʺϳÉÕϰ­¶øÏ¸°ûµòÍö£¬´Ó¶ø´ïµ½°ÐÏòÖÎÁÆ(²Î¿¼ÎÄÏ× 4.Sara E.Shinnick, MSN, RN, et al.Managing Hypersensitivity to Asparaginasein Pediatrics, Adolescents, and Young Adults[J].Journal of Pediatric OncologyNursing, 2013; 30 (2):63 - 77.)¡£ÔÚÖÎÁÆALLÁÆÐ§È·ÇУ¬ÏÖÒѳÉΪ²»¿ÉÒÔÌæ´úµÄÁªºÏÖÎÁƼ±ÐÔÁܰÍϸ°û°×Ѫ²¡µÄÒ»ÏßÒ©Îï¡£
[0004]¹úÄÚÍâ²â¶¨ÄÚÔ´ÐÔ°±»ùËáµÄÖ÷Òª¼ì²â·½·¨£¬¶Ô°±»ùËá½øÐÐÑÜÉú´¦Àíºó¸ßЧҺÏàÉ«Æ×Ó«¹â¼ì²âÆ÷²â¶¨£¬²Ù×÷²½Öè·±Ëö£¬»òÕßÒºÖÊÁªÓòⶨ£¬¾ùÓÐÒ»¶¨µÄ±×¶Ë¡£±ê×¼ÇúÏßµÄÅäÖÆÊ±ÓвÉÓô¿Ë®ÈܽâϵÁÐŨ¶È°±»ùËáµÄ»ò½«Ñª½¬(ѪÇå)ÑùÆ·Ï¡Êͼ¸±¶ºóÔÙÈܽâϵÁÐŨ¶È°±»ùËáµÄ£¬ºóÕßÈÔ´æÔÚÒ»¶¨Å¨¶ÈÄÚÔ´ÐÔ°±»ùËá¡£ÕâЩ·½·¨¾ùÎÞ·¨µÃµ½²»º¬ÄÚÔ´ÐÔ°±»ùËáµÄ¿Õ°×Ѫ½¬£¬À´×¼È·²â¶¨ÌåÄÚÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶È£¬ÌرðÊDz»ÄÜ׼ȷ·´Ó³»¼ÕßÌåÄÚµÍŨ¶ÈÃŶ¬õ£°·ºÍ¹È°±õ£°·µÄ¶¯Ì¬±ä»¯£¬ÓÃÓÚÆÀ¼ÛÃŶ¬õ£°·Ã¸ÔÚÌåÄÚҩЧ¡£
[0005]Ŀǰ¹úÄÚÍâÉÐÎÞÎÄÏ×±¨µÀÓйØÈçºÎ´¦ÀíÆäËûÄÚÔ´ÐÔ°±»ùËᣬµÃµ½¿Õ°×»ùÖÊÓÃÓÚ±ê×¼ÇúÏßµÄÅäÖÆ£¬ÒԴﵽ׼ȷ²â¶¨Ñª½¬(ѪÇå)ÑùÆ·ÖÐÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶È¡£

¡¾·¢Ã÷ÄÚÈÝ¡¿

[0006]±¾·¢Ã÷µÄÄ¿µÄÔÚÓÚÌṩһÖÖ¿ÉÒÔ׼ȷ²â¶¨Ñª½¬»òѪÇåÑùÆ·ÖÐÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬±¾·¢Ã÷µÄ·½·¨¿ÉÓÃÓÚ׼ȷ¡¢¼ò±ã¡¢¿ìËÙµØÆÀ¼Û°×Ѫ²¡»¼ÕßÖÎÁÆÒ©ÎïÃŶ¬õ£°·Ã¸µÄÌåÄÚҩЧ¡£
[0007]±¾·¢Ã÷µÄÖ÷Òª¼¼Êõ·½°¸ÊÇ:²ÉÓÃÒºÖÊÁªÓÃÖÊÆ×ÒÇÀ´²â¶¨Ñª½¬»òѪÇåÑùÆ·ÖÐÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶È£¬ÎªÊ¹²â¶¨³öµÄÊýֵ׼ȷ£¬Ê×ÏÈÒª½â¾öµÄ¼¼ÊõÎÊÌâÊÇÈçºÎµÃµ½²»º¬ÄÚÔ´ÐÔ°±»ùËáµÄ¿Õ°×Ѫ½¬»òѪÇåÒ»¼´±¾·¢Ã÷µÄ·¢Ã÷µãÖ®Ò»¡°¿Õ°×»ùÖÊ´¦Àí·½·¨¡±£»Æä´ÎÒª½â¾öµÄ¼¼ÊõÎÊÌâÊÇÈç¹û´ý²âµÄѪ½¬»òѪÇåÑùÆ·Öл¹º¬ÓÐÃŶ¬õ£°·Ã¸£¬Ôò»áÓ°Ïì´ý²âµÄѪ½¬»òѪÇåÑùÆ·ÖÐÄÚÔ´ÐÔ°±»ùËáŨ¶ÈµÄ׼ȷÐÔ£¬Òò´ËÒª¾¡¿ìʹ´ý²âµÄѪ½¬»òѪÇåÑùÆ·ÖеÄÃŶ¬õ£°·Ã¸Ãð»îÒ»¼´±¾·¢Ã÷µÄ·¢Ã÷µãÖ®Ò» ¡°´ý²âѪ½¬»òѪÇåÑùÆ·µÄǰ´¦Àí·½·¨¡±¡£
[0008]±¾·¢Ã÷ÌṩÁËÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬¸Ã·½·¨°üÀ¨:
[0009]A¡¢¿Õ°×»ùÖÊ´¦Àí
[0010]½«½¡¿µÈËÌåѪ½¬»òѪÇåÑùÆ·¼ÓÈëÃŶ¬õ£°·Ã¸»ìÔÈ£¬·ÅÖÃÖÁÉÙlOmin£¬´ýѪ½¬»òѪÇåÑùÆ·ÀïÖеĹȰ±õ£°·ÓëÃŶ¬õ£°·È«²¿±»Ïû³ý¸É¾»£¬¼ÓÈë΢Á¿Å¨H3PO4»òHCLµ÷½ÚpHÖÁ3-5£¬¼ÓÈëÒÈø»ìÔÈ£¬·ÅÖÃIOminÒÔÉÏ£¬µÃ¿Õ°×»ùÖÊ¡£
[0011]±¾·¢Ã÷µÄ¿Õ°×»ùÖÊ´¦Àí·½·¨£¬Ê¹½¡¿µÈËÌåѪ½¬»òѪÇåÑùÆ·¾­¹ýÃŶ¬õ£°·Ã¸´¦ÀíºóÔÙÓÃÑÎËá»òÁ×Ëáµ÷½ÚPHºó¼ÓÈëÒÈøʹÃŶ¬õ£°·Ã¸Ê§»î£¬×÷Ϊ¿Õ°×»ùÖÊÅäÖÆ±ê×¼ÇúÏߣ¬²â¶¨ÃŶ¬õ£°·ºÍ¹È°±õ£°·µÄŨ¶È¡£
[0012]´Ë¿Õ°×»ùÖʿɱ£´æ°ë¸öÔÂÖÁÒ»¸öÔ£¬Öظ´Ê¹Óá£
[0013]½Ï¼ÑµØ£¬ËùÊöµÄ²½ÖèAÖУ¬Ñª½¬»òѪÇåÑùÆ·ÎÒÃÇÒÔ15mlΪµ¥Î»×÷ΪÑо¿»ù´¡£¬ÃŶ¬õ£°·Ã¸Á¿ÒÔ100IUΪÒË£¬¿É´óÓڸõ¥Î»£¬Å¨H3PO4»òHCLÒÔ100-200 ¦Ì IΪ¼Ñ£¬ÒÈøÁ¿È¡¾öÓÚ¼ÓÈëÃŶ¬õ£°·Ã¸µÄЧ¼Û£¬½¨Òé10-100IU¡£
[0014]½øÒ»²½µØ£¬±¾·¢Ã÷ÌṩÁËÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬¸Ã·½·¨°üÀ¨²½Ö覡¡¢¿Õ°×»ùÖÊ´¦Àí£¬ÒÔ¼°:
[0015]B¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄǰ´¦Àí
[0016]½«´ý²â(»¼Õß)Ѫ½¬»òѪÇåÑùÆ·£¬¼ÓÈë΢Á¿Å¨H3PO4»òHCLµ÷½ÚpHÖÁ3_5£¬¼ÓÈëÒÈø»ìÔÈ£¬·ÅÖÃIOminÒÔÉÏ£¬-80¡ãC±ùÏäÀä¶³±£´æ£¬»ò¼ÓÈëÓлúÈÜýµ°°×³Áµí¼Á½øÐе°°×³Áµí½øÐмì²â¡£
[0017]±¾·¢Ã÷µÄ´ý²âѪ½¬»òѪÇåÑùÆ·µÄǰ´¦Àí·½·¨£¬Ê¹´ý²âÑùÆ·ÖеÄÃŶ¬õ£°·Ã¸»îÐÔÃðʧ£¬ÄÜ׼ȷ²â¶¨´ý²âÑùÆ·ÖÐÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·µÄŨ¶È¡£
[0018]½Ï¼ÑµØ£¬ËùÊöµÄ²½ÖèBÖУ¬ÓлúÈÜýµ°°×³Áµí¼ÁΪ80-90%¼×´¼»ò80-90%ÒÒëæ¡£
[0019]±¾·¢Ã÷µÄÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬¸Ã·½·¨ÔÚ²½ÖèA¡¢¿Õ°×»ùÖÊ´¦Àí£¬ÒÔ¼°²½ÖèB¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄǰ´¦Àí»ù´¡ÉÏ£¬¿ÉÒÔ²ÉÓñ¾¡¾¼¼ÊõÁìÓò¡¿¹«ÖªµÄ¸ßЧҺÏàÉ«Æ×ÒÇ»òÒºÖÊÁªÓÃÉ«Æ×ÒÇÀ´¼ì²â´ý²âѪ½¬»òѪÇåÑùÆ·ÖеÄÄÚÔ´ÐÔ°±»ùËáµÄŨ¶È¡£
[0020]±¾·¢Ã÷ËùÊöµÄ¸ßЧҺÏàÉ«Æ×ÒÇ»òÒºÖÊÁªÓÃÉ«Æ×ÒÇ£¬¿É²Î¿¼ÎÄÏ×:
[0021]5.Sai P.Bathenaaj Jiangeng Huangaj Adrian A.Epsteinbj et al.Rapid andreliable quantitation of amino acids and myo-1nositol in mouse brain by highperformance liquid chromatography and tandem mass spectrometry[J].Journal ofChromatography B£¬2012;893-894:15-20.[0022]6.J.J.Pesek, M.T.Matyska, J.A.Loo, et al.Analysis of hydrophilicmetabolites in physiological fluids by HPLC - MS using a silica hydride-basedstationary phase[J].J.Sep.Sc1.2009;(32):2200 - 2208.[0023]7.Katharina Diepoldl, Katrin Bomans, Michael ffiedmann, et al.SimultaneousAssessment of Asp Isomerization and Asn Deamidation in RecombinantAntibodies by LC-MS following Incubation at Elevated Temperatures[J].Plosone, 2012; 7 (I):e30295.µÈ¡£
[0024]±¾·¢Ã÷µÄÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬¸Ã·½·¨»¹°üÀ¨:
[0025]C¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄ·ÖÀëÓë·ÖÎö
[0026]´ý²âѪ½¬»òѪÇåÑùÆ·¾­ËáÐÔÁ÷¶¯ÏàÔÚË®ÐÔÒºÏàÉ«Æ×Öù·ÖÀëºó£¬ÓÃÖÊÆ×¼ì²âÆ÷¼ì²âÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶È¡£
[0027]½Ï¼ÑµØ£¬ËùÊöµÄ²½ÖèCÖУ¬ÒºÏàÉ«Æ×Ìõ¼þ:·ÖÎöÖùΪZorbax SB-AqC18Column (250 X 4.6mml.D., 5 ¦Ì m)É«Æ×Öù;Á÷¶¯ÏàΪ¼×´¼-Ë®(º¬ 0.1% ¼×Ëá):20-80 (V/V)£»Á÷ËÙΪ0.5ml/min ;ÖùÎÂΪ20¡ãC ;½øÑùÁ¿ÎªI ¦Ì I¡£
[0028]ËùÊöµÄÖÊÆ×¼ì²âÆ÷£¬²ÉÓÃAB Sciex3200Qtrap£¬´®ÁªÖÊÆ×ÒÇ£¬ÃÀ¹úÓ¦ÓÃÉúÎïϵͳ¹«Ë¾£»ÖÊÆ×Ìõ¼þ:Àë×ÓԴΪµçÅçÎíÀë×ÓÔ´(ESIÔ´)£¬ÅçÎíµçѹΪ5.5kV£¬Àë×Ó´«Êäëϸ¹ÜζÈΪ5500C £»Gasl (N2)ѹÁ¦Îª55Arb, Gas2 (N2)ѹÁ¦Îª50Arb£¬Á±Æø(N2)ѹÁ¦Îª120Arb ;Åö×²Æø(Ar)ѹÁ¦ÎªMedium £»DPµçѹΪ30eV(¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ëá);CEµçѹ·Ö±ðΪ24eV(¹È°±õ£°·)¡¢22eV (ÃŶ¬õ£°·)ºÍ12eV (»·Ë¿°±Ëá);CXPµçѹ·Ö±ðΪ3eV (¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ëá)£»EPµçѹ·Ö±ðΪ4eV (¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ëá)£»ÕýÀë×Ó·½Ê½¼ì²â£»É¨Ã跽ʽΪѡÔñ·´Ó¦¼à²â(MRM);ÓÃÓÚ¶¨Á¿·ÖÎöµÄÀë×Ó¶Ô·Ö±ðΪm/zl47.1 ¡ª m/z83.9 (¹È°±õ£°·)¡¢m/zl33.1 ¡ª m/z73.9 (ÃŶ¬õ£°·)ºÍm/zl02.9 ¡ª m/z75.1 (»·Ë¿°±Ëá);ɨÃèʱ¼äΪ 0.2s¡£
[0029]ÓëÆäËûÒºÏàÉ«Æ×»òÒºÖÊÁªÓüì²âÄÚÔ´ÐÔ°±»ùËáÏà±È£¬±¾·¢Ã÷µÄ·½·¨µÄÓÐÒæÐ§¹ûÈçÏÂ:
[0030]Ѫ½¬»òѪÇåÑùÆ·¾­¹ýÃŶ¬õ£°·Ã¸´¦ÀíºóµÃµ½²»º¬ÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·µÄ¿Õ°×Ѫ½¬»òѪÇåÑùÆ·£¬´Ó¶øÄÜ׼ȷ·´Ó¦ÄÚÔ´ÐÔ°±»ùËáÌåÄÚÏû³ý£¬Ò²¸ü½Ó½üÕæÊµµÄÌáÈ¡»ØÊÕÂʺÍ׼ȷ¶È¡£
[0031]ÑÎËá»òÁ×Ëáµ÷½ÚpHÖÁ3-5ºóÔÙ¼ÓÈëÒÈøʹÃŶ¬õ£°·Ã¸Ê§»î£¬²»Ó°ÏìÃŶ¬õ£°·ºÍ¹È°±õ£°·¼ÓÈëºóµÄÎȶ¨ÐÔ£¬Í¬Ê±ÄܼõÉÙѪÑùÔÚ±£´æ»ò¼ì²â¹ý³ÌÖвúÉúʱ¼ä¶ÏÃŶ¬õ£°·Ã¸¼ÌÐøÏû³ýÃŶ¬°±ËáºÍ¹È°±õ£°·Å¨¶È²úÉúµÄÎó²î£¬¸üÊʺÏÁÙ´²°×Ѫ²¡²¡ÈË·þÓÃÃŶ¬õ£°·Ã¸ºóÁÆÐ§µÄ¼à²â¡£
[0032]80-90%¼×´¼»òÒÒëæµ°°×³Áµí±£Ö¤ÁËÃŶ¬õ£°·ºÍ¹È°±õ£°·Ìرð¸ßŨ¶È³ä·ÖÌáÈ¡¡£
[0033]±¾·¢Ã÷µÄ·½·¨²Ù×÷¼òµ¥¡¢¿ìËÙ¡¢ÁéÃô¡¢Öظ´ÐԺᢷÖÎöÖÜÆÚ¶Ì£¬²»Ó°ÏìÍâÔ´ÐÔÃŶ¬õ£°·ºÍ¹È°±õ£°·¼ÓÈëºóµÄÎȶ¨ÐÔ£¬ÊʺÏÁÙ´²°×Ѫ²¡²¡ÈË·þÓÃÃŶ¬õ£°·Ã¸ºóÁÆÐ§µÄ¼à²â¡£
[0034]±¾·¢Ã÷µÄ·½·¨ÎÞÐè°º¹óµÄÉ豸ºÍÊÔ¼Á£¬Ñª½¬ÓÃÁ¿ÉÙ£¬³É±¾µÍµÈ£¬Êʺϳ£¹æÖÎÁÆÒ©Îï¼à²â¡£¡¾×¨Àû¸½Í¼¡¿

¡¾¸½Í¼ËµÃ÷¡¿
[0035]ͼ1ÊÇÃŶ¬õ£°·Ã¸Ð§¼ÛÓëµ×ÎïÏû³ýʱ¼ä¹ØÏµ£»
[0036]ͼ2Êǿհ×Ѫ½¬µÄµäÐÍÉ«Æ×ͼ£»
[0037]ͼ3ÊǾ­¹ýÔ¤´¦ÀíºóµÃµ½µÄ²»º¬¹È°±õ£°·¡¢ÃŶ¬õ£°·µÄ¿Õ°×Ѫ½¬»ùÖʵĵäÐÍÉ«Æ×ͼ£»
[0038]ͼ4Êǿհ×Ѫ½¬+±ê׼Ʒ¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍÄڱ껷˿°±ËáµÄµäÐÍÉ«Æ×ͼ£»
[0039]ͼ5ÊÇ·þÓÃÃŶ¬õ£°·Ã¸°×Ѫ²¡»¼ÕßµÄѪ½¬µÄµäÐÍÉ«Æ×ͼ£»
[0040]ÆäÖзå1:»·Ë¿°±Ëá(ÄÚ±ê)£»·å2:ÃŶ¬õ£°·£»·å3:¹È°±õ£°·¡£
¡¾¾ßÌåʵʩ·½Ê½¡¿
[0041]ÏÂÃæ½áºÏ¸½Í¼¼°ÊµÊ©Àý¶Ô±¾·¢Ã÷½øÐÐÏêϸÃèÊö£¬µ«±¾·¢Ã÷µÄʵʩ²»½öÏÞÓÚ´Ë¡£
[0042]ÏÂÊöʵʩÀýÖеÄʵÑé·½·¨£¬ÈçÎÞÌØÊâ˵Ã÷£¬¾ùΪ³£¹æ·½·¨¡£
[0043]ÒºÖÊÌõ¼þ:AB Sciex3200Qtrap,´®ÁªÖÊÆ×ÒÇ£¬ÃÀ¹úÓ¦ÓÃÉúÎïϵͳ¹«Ë¾£»µº½òÒºÏàÉ«Æ×ÒÇ£¬°üÀ¨LC-20ADXR±ÃÁ½Ì¨¡¢D¢Ç-20A3ÔÚÏßÍÑÆøÒÇ¡¢SIL-20ACCXR×Ô¶¯½øÑùÆ÷¡¢CT0-20AC
ÖùÎÂÏä¡£
[0044]ÒºÏàÉ«Æ×Ìõ¼þ:·ÖÎöÖùΪZorbax SB-Aq C18Column (250 X 4.6mml.D.£¬5 ¦Ì m)É«Æ×Öù£»Á÷¶¯ÏàΪ¼×´¼-Ë®(º¬0.1%¼×Ëá):20-80 (V/V);Á÷ËÙΪ0.5ml/min ;ÖùÎÂΪ20¡ãC ;½øÑùÁ¿ÎªI ¦Ì I¡£`
[0045]ÖÊÆ×Ìõ¼þ:Àë×ÓԴΪµçÅçÎíÀë×ÓÔ´(ESIÔ´)£¬ÅçÎíµçѹΪ5.5kV£¬Àë×Ó´«Êäëϸ¹ÜζÈΪ550¡ãC£»Gasl(N2)ѹÁ¦Îª55Arb£¬Gas2 (N2)ѹÁ¦Îª50Arb£¬Á±Æø(N2)ѹÁ¦Îª120Arb ;Åö×²Æø(Ar)ѹÁ¦ÎªMedium £»DPµçѹΪ30eV (¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ëá)£»CEµçѹ·Ö±ðΪ24eV (¹È°±õ£°·)¡¢22eV (ÃŶ¬õ£°·)ºÍ12eV (»·Ë¿°±Ëá)£»CXPµçѹ·Ö±ðΪ3eV (¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ëá)£»EPµçѹ·Ö±ðΪ4eV (¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ëá)£»ÕýÀë×Ó·½Ê½¼ì²â£»É¨Ã跽ʽΪѡÔñ·´Ó¦¼à²â(MRM);ÓÃÓÚ¶¨Á¿·ÖÎöµÄÀë×Ó¶Ô·Ö±ðΪm/zl47.1 ¡ª m/z83.9 (¹È°±õ£°·)¡¢m/zl33.1 ¡ª m/z73.9 (ÃŶ¬õ£°·)ºÍ m/zl02.9 ¡ª m/z75.1 (»·Ë¿°±Ëá);ɨÃèʱ¼äΪ0.2s¡£
[0046]ʵʩÀý1:²»Í¬±ÈÀý¼×´¼-Ë®»ò²»Í¬±ÈÀýÒÒëæ-Ë®ÈÜÒº¶Ô°±»ùËáÌáÈ¡ÂÊ¿¼²ì
[0047]ѪÇåÑùÆ·ÓÚÊÒÎÂ(20¡ãC )ÏÂ×ÔÈ»ÈÚ»¯ºóÈ¡200 ¦Ì L¼ÓÈë800 ¦Ì L²»Í¬±ÈÀý¼×´¼-Ë®»ò²»Í¬±ÈÀýÒÒëæ-Ë®ÈÜÒº£¬ÎÐÐý15ÃëºóÓÚIlOOOrpmÀëÐÄ7·ÖÖÓ¡£×ªÒÆÉÏÇåÒººó×ªÒÆÖÁ×Ô¶¯½øÑùÆ÷СƿÖУ¬×Ô¶¯½øÑùÆ÷ÄÚ20¡ãCϵȴý½øÑù(ÿ¸öѪÑùǰ´¦Àí¹ý³Ì¾ùÔÚ3hÄÚÍê³É)¡£
[0048]±í1²»Í¬±ÈÀý¼×´¼-Ë®»ò²»Í¬±ÈÀýÒÒëæ-Ë®ÈÜÒº¶Ô°±»ùËáÌáÈ¡ÂÊ¿¼²ì
[0049]
²» |sj ±È ^Sample!I Sample 2 I Sample 3Sample 4
frl[½éºÍ1 (·åÃæ»ý) I (·åÃæ»ý)(ä®Ãæ»ý)(·åÃæ»ý)
Asn Gin I Ass I Gln I Am Gto Asn I GlnÈÜ_II[II
[0050]
¡¾È¨ÀûÒªÇó¡¿
1.Ò»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ£¬¸Ã·½·¨°üÀ¨: A¡¢¿Õ°×»ùÖÊ´¦Àí ½«½¡¿µÈËÌåѪ½¬»òѪÇåÑùÆ·¼ÓÈëÃŶ¬õ£°·Ã¸»ìÔÈ£¬·ÅÖÃÖÁÉÙlOmin£¬´ýѪ½¬»òѪÇåÑùÆ·ÀïÖеĹȰ±õ£°·ÓëÃŶ¬õ£°·È«²¿±»Ïû³ý¸É¾»£¬¼ÓÈë΢Á¿Å¨H3PO4»òHCLµ÷½ÚpHÖÁ3-5£¬¼ÓÈëÒÈø»ìÔÈ£¬·ÅÖÃIOminÒÔÉÏ£¬µÃ¿Õ°×»ùÖÊ¡£
2.¸ù¾ÝȨÀûÒªÇó1ËùÊöµÄÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ£¬¸Ã·½·¨»¹°üÀ¨: B¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄǰ´¦Àí ½«´ý²âѪ½¬»òѪÇåÑùÆ·£¬¼ÓÈë΢Á¿Å¨H3P04»òHCLµ÷½ÚpHÖÁ3_5£¬¼ÓÈëÒÈø»ìÔÈ£¬·ÅÖÃIOminÒÔÉÏ£¬ÔÙ¼ÓÈëÓлúÈÜýµ°°×³Áµí¼Á½øÐе°°×³Áµí¡£
3.¸ù¾ÝȨÀûÒªÇó1»ò2ËùÊöµÄÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ£¬¸Ã·½·¨»¹°üÀ¨: C¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄ·ÖÀëÓë·ÖÎö ²ÉÓÃÒºÏàÉ«Æ×ºÍÖÊÆ×ÁªÓ÷¨À´¼ì²â´ý²âѪ½¬»òѪÇåÑùÆ·ÖеÄÄÚÔ´ÐÔ°±»ùËáµÄŨ¶È¡£
4.¸ù¾ÝȨÀûÒªÇó1»ò2ËùÊöµÄÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÊöµÄ²½ÖèAÖУ¬Ñª½¬»òѪÇåÑùƷΪ15ml£¬ÃŶ¬õ£°·Ã¸> 100IU£¬Å¨H3PO4 »ò HCL Ϊ 100-200 ¦Ì 1£¬ÒÈøΪ 10-100IU¡£
5.¸ù¾ÝȨÀûÒªÇó1»ò2ËùÊöµÄÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ£¬ËùÊöµÄ²½ÖèBÖУ¬ÓлúÈÜýµ°°×³Áµí¼ÁΪ80-90%¼×´¼»ò80-90%ÒÒÔÂÇà¡£
6.¸ù¾ÝȨÀûÒªÇó1»ò2ËùÊöµÄÒ»ÖÖÒºÖÊÁªÓòⶨÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶ÈµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ£¬¸Ã·½·¨»¹°üÀ¨: C¡¢´ý²âѪ½¬»òѪÇåÑùÆ·µÄ·ÖÀëÓë·ÖÎö ´ý²âѪ½¬»òѪÇåÑùÆ·¾­ËáÐÔÁ÷¶¯ÏàÔÚË®ÐÔÒºÏàÉ«Æ×Öù·ÖÀëºó£¬ÓÃÖÊÆ×¼ì²âÆ÷¼ì²âÄÚÔ´ÐÔ°±»ùËáÃŶ¬õ£°·ºÍ¹È°±õ£°·Å¨¶È£» ÒºÏàÉ«Æ×Ìõ¼þ:·ÖÎöÖùΪZorbax SB-Aq C18column250 X 4.6mml.D., 5 ¦Ì mÉ«Æ×Öù£»Á÷¶¯ÏàΪ¼×´¼-Ë®º¬0.1%¼×Ëá:20-80V/V ;Á÷ËÙΪ0.5ml/min ;ÖùÎÂΪ20¡ãC ;½øÑùÁ¿ÎªI ¦Ì I¡£ ËùÊöµÄÖÊÆ×¼ì²âÆ÷£¬²ÉÓÃAB Sciex3200Qtrap£¬´®ÁªÖÊÆ×ÒÇ£¬ÃÀ¹úÓ¦ÓÃÉúÎïϵͳ¹«Ë¾£»ÖÊÆ×Ìõ¼þ:Àë×ÓԴΪµçÅçÎíÀë×ÓÔ´£¬ÅçÎíµçѹΪ5.5kV£¬Àë×Ó´«Êäëϸ¹ÜζÈΪ550¡ãC £»GaslѹÁ¦Îª55Arb£¬Gas2ѹÁ¦Îª50Arb£¬Á±ÆøÑ¹Á¦Îª120Arb ;Åö×²ÆøArѹÁ¦ÎªMedium £»DPµçѹΪ30eV¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ë᣻CEµçѹ·Ö±ðΪ24eV¹È°±õ£°·¡¢22eVÃŶ¬õ£°·ºÍ12eV»·Ë¿°±Ë᣻CXPµçѹ·Ö±ðΪ3eV¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ë᣻EPµçѹ·Ö±ðΪ4eV¹È°±õ£°·¡¢ÃŶ¬õ£°·ºÍ»·Ë¿°±Ë᣻ÕýÀë×Ó·½Ê½¼ì²â£»É¨Ã跽ʽΪѡÔñ·´Ó¦¼à²â£»ÓÃÓÚ¶¨Á¿·ÖÎöµÄÀë×Ó¶Ô·Ö±ðΪm/zl47.1 ¡ª m/z83.9¹È°±õ£°·¡¢m/zl33.1 ¡ª m/z73.9ÃŶ¬õ£°·ºÍm/zl02.9 ¡ª m/z75.1»·Ë¿°±Ë᣻ɨÃèʱ¼äΪ0.2s¡£
¡¾Îĵµ±àºÅ¡¿G01N30/02GK103822981SQ201410061791
¡¾¹«¿ªÈÕ¡¿2014Äê5ÔÂ28ÈÕ ÉêÇëÈÕÆÚ:2014Äê2ÔÂ24ÈÕ ÓÅÏÈȨÈÕ:2014Äê2ÔÂ24ÈÕ
¡¾·¢Ã÷Õß¡¿Íõ׿, ÕÅÎľ², ¸ßÉê, Íò˼»Û, ÐíÃÏÑ©, ¶¡Ñ©Ó¥, ºÎ½ð·ï, ¶¡éª ÉêÇëÈË:ÖйúÈËÃñ½â·Å¾üµÚ¶þ¾üÒ½´óѧ

  • רÀûÃû³Æ£ºÒ»ÖÖ×é֯ƬƯϴºÐµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÊôÓÚ»ù´¡ÉúÎïѧʵÑ鸨Öú×°Ö㬾ßÌåÉæ¼°Ò»ÖÖ×é֯ƬƯϴºÐ¡£ ±³¾°¼¼Êõ£ºÃâÒß×éÖ¯»¯Ñ§(immunohistochemistry£¬IHC)¼¼ÊõÔÚ×é֯ѧ»ù´¡Ñо¿ºÍ²¡ÀíÕï¶Ï µÄÓ¦ÓÃÔ½À´Ô½¹ã·º£¬ËüÊÇ
  • רÀûÃû³Æ£º±ê¼Ç·ÖÎö¹ÌÏà²ÄÁϱíÃæ»î»¯·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷ÊôÓÚÉúÎï±êÑù(Ѫ¡¢Äò¼°ÆäËû)±ê¼Ç·ÖÎö²ÄÁϵÄÖÆ±¸·½·¨¡£¹ÌÏà·¨Êǵ±½ñ±ê¼Ç·ÖÎöµÄ·¢Õ¹·½Ïò£¬±êÖ¾×űê¼Ç·ÖÎöµÄˮƽ¡£ÓëÒºÏà·¨±È£¬¹ÌÏà·¨ÌØ±ðÊǼÐÐĹÌÏà·¨£¬¸üÁéÃô£¬¸ü׼ȷ£¬²Ù×÷¸ü¼òµ¥£¬¸üÊʺÏ×Ô¶¯»¯¡£¹Ì
  • רÀûÃû³Æ£º¼òÒ×´¹Ö±¶È²âÁ¿¹¤¾ßµÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖ¼òÒ×´¹Ö±¶È²âÁ¿¹¤¾ß£¬ÊôÓÚ½¨Öþ¹¤³ÌÁìÓò¡£±³¾°¼¼Êõ£ºÏÖÓÐÓÃÏß×¹²âÁ¿ÊúÏò½á¹¹´¹Ö±¶È×°Öü°¼¼ÊõÊǽ«Ïß×¹¹ÒÓÚÏßÉÏ£¬ÈËÅÀ¸ßµ½ÊúÏò½á¹¹¶¥½«Ïß×¹Íùϵõ²âÁ¿ÊúÏò½á¹¹´¹Ö±¶È¡£´ËÏî×ö·¨µÄȱµãÊÇÈËÐè
  • רÀûÃû³Æ£ºËáÔ¡×ǶÈרÓòâÊÔÒǵÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖ²âÊÔÒÇÆ÷£¬ÌرðÊÇÉæ¼°Ò»ÖÖÕ³½ºÏËάÉú²úÖнéÖÊËáÔ¡½à¾»¶È²âÊÔרÓÃËáÔ¡×ǶÈרÓòâÊÔÒÇ¡£±³¾°¼¼Êõ£ºÄ¿Ç°¹úÄÚͨÓÃÈâÑÛ¹Û²ìËáÔ¡µÄ½à¾»¶È¡£Êǽ«Ò»¶¨Á¿µÄËáÔ¡ÈÜÒºµ¹Èë²£Á§ÊÔ¹ÜÄÚ°ÑÊԹܷÅÈëÒ»¸öÓÐ
  • רÀûÃû³Æ£º¹âÏ˹âդȺʱÑÓÆ×µÄ²î¶¯¸ÉÉæ²âÁ¿×°Öü°Æä²âÁ¿·½·¨¼¼ÊõÁìÓò£º±¾·¢Ã÷Éæ¼°¹âÏ˹âÕ¤£¬ÌرðÊÇÒ»ÖÖ¹âÏ˹âդȺʱÑÓÆ×ºÍȺʱÑÓɫɢµÄ²î¶¯¸ÉÉæ²âÁ¿×°Öü°Æä²âÁ¿·½·¨£¬Ö÷ÒªÓ¦ÓÃÓÚ¹âÏËͨÐÅÖйâÏ˹âդɫɢ²¹³¥Æ÷¼þµÄ²âÊÔºÍÆäËûÓйعâÆ×²âÁ¿ºÍµ÷г·½ÃæµÄÓ¦Óᣱ³
  • רÀûÃû³Æ£º¶à¹¦ÄܳߵÄÖÆ×÷·½·¨¼¼ÊõÁìÓò£º±¾ÊµÓÃÐÂÐÍÉæ¼°Ò»ÖÖ½ÌѧÓþߣ¬ÓÈÆäÉæ¼°Ò»Öֶ๦Äܳß¡£ ±³¾°¼¼Êõ£ºÑ§Ð£½ÌʦÔÚ¼¸ºÎ½Ìѧʱ£¬´«Í³ÉÏÒ»Ö±ÓÃÈý½Ç°å¡¢°ëÔ²ÒÇÀ´½øÐнǡ¢Èý½ÇÐμ°¶à±ßÐÎ µÄ½Ìѧ£¬¶àÖֽ̾ßÅäºÏʹÓã¬ÔÚºÚ°åÉÏ»­½Ç½Ï·ÑÁ¦·Ñʱ£¬ÇÒûÓпɹ©ÑÝʾµÄ
ɽ¶«ÑÇÐÇÓÎÏ·¹ÙÍø»ú´²ÓÐÏÞ¹«Ë¾
È«¹ú·þÎñÈÈÏߣº13062023238
µç»°£º13062023238
µØÖ·£ºëøÖÝÊÐÁúȪ¹¤ÒµÔ°68ºÅ
¹Ø¼ü´Ê£ºÏ³´²£¬Êý¿ØÏ³´²£¬ÁúÃÅϳ´²
¹«Ë¾¶þάÂë
Copyright 2010-2024 °æÈ¨ËùÓÐ All rights reserved ³ICP±¸19044495ºÅ-12
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿